Telmisartan Tablets

Notice ID:SPE2E2-24-R-0015

Amendment 0004 has been made to accomdate for solicitation changes pursuant to the authority of CD 2025-O0003 and CD 2025-O0004.

Department/Ind.Agency Subtier Office
DEPT OF DEFENSE DEFENSE LOGISTICS AGENCY DLA TROOP SUPPORT
NAICS 325412 - Pharmaceutical Preparation Manufacturing
  PSC   6505 DRUGS AND BIOLOGICALS
LOCATION: Not Given
Primary Contact
Courtney Hunter-Stangler
c**********************r@dla.mil
Not Given
Alt Contact
Jason Wray
j********y@dla.mil
445-***-6304

Links (0)

Attachments (5)

Document
Size
Access
Updated
SF30_SPE2D224R00150004.PDF
19.17 KB
Public
Mar 27, 2025
SF30_SPE2D224R00150003.PDF
18.58 KB
Public
Feb 25, 2025
SF30_SPE2D224R00150002.PDF
18.19 KB
Public
Feb 21, 2025
SF30_SPE2D224R00150001.PDF
18.19 KB
Public
Feb 7, 2025
Telmisartan Solicitation - SPE2D2-24-R-0015 - Final.pdf
1.51 MB
Public
Jan 8, 2025


Data sourced from SAM.gov. View Official Posting »

Notification